Search results:

Results for ""

Covis Statement on FDA Decision to Withdraw Approval of Makena®

Press ReleaseCovis Statement on FDA Decision to Withdraw Approval of Makena®Zug, Switzerland, April 7, 2023 – Following the U.S. Food and Drug Administration's decision, Covis Pharma Group ("Covis") is effectuating the withdrawal of Makena® (hydroxyprogesterone...

2023

News release 2023

Covis Pharma Reports on FDA Advisory Committee Hearing for Makena®

Press ReleaseCovis Pharma Reports on FDA Advisory Committee Hearing for Makena® Zug, Switzerland, 19 October 2022 – Covis Pharma Group (the “Company”), today reported that the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee to the U.S. Food and Drug...

Lanoxin WAC

LANOXIN® (digoxin) InjectionInformation for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131The prices listed below are Wholesaler Acquisition Costs (WAC). Information about WAC of these drugs is being provided to Colorado...

Tudorza WAC

TUDORZA® PRESSAIR® (aclidinium bromide inhalation power)Information for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131The prices listed below are Wholesaler Acquisition Costs (WAC). Information about WAC of these drugs is...

Feraheme WAC

FERAHEME® (ferumoxytol injection)Information for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131The prices listed below are Wholesaler Acquisition Costs (WAC). Information about WAC of these drugs is being provided to...

Prilosec WAC

PRILOSEC® (omeprazole magnesium) for Delayed-Release Oral SuspensionInformation for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131The prices listed below are Wholesaler Acquisition Costs (WAC). Information about WAC of...

Duaklir WAC

DUAKLIR® PRESSAIR®(aclidinium bromide and formoterol fumarate inhalation powder)Information for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131The prices listed below are Wholesaler Acquisition Costs (WAC). Information about...

Alvesco WAC

ALVESCO® (ciclesonide) Inhalation AerosolInformation for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131The prices listed below are Wholesaler Acquisition Costs (WAC). Information about WAC of these drugs is being provided...

Covis Pharma Group Announces Executive Leadership Appointment in Canada

Press ReleaseCovis Pharma Group Announces Executive Leadership Appointment in CanadaZug, Switzerland, 14 July 2022 – Covis Pharma Group (the "Company"), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening...

Feraheme ISI

Feraheme® ISI (ferumoxytol injection)Feraheme Important Safety InformationWARNING: RISK FOR SERIOUS HYPERSENSITIVITY/ANAPHYLAXIS REACTIONS Fatal and serious hypersensitivity reactions including anaphylaxis have occurred in patients receiving Feraheme.  Initial...

Covis Pharma Provides Update on FDA Public Hearing for Makena®

Press ReleaseCovis Pharma Provides Update on FDA Public Hearing for Makena®Zug, Switzerland, June 14, 2022 – Covis Pharma GmbH, an affiliate of Group S.à r.l. (collectively, “Covis”), announced today that the U.S. Food & Drug Administration (FDA) anticipates...

Development

Product DevelopmentToo many patients and families continue to experience the effects of serious health conditions that have no available treatments or cures. Covis seeks to collaborate on and acquire promising therapies at various stages of development, and advance...

ISR Concept Form

ISR Concept FormCOVIS INVESTIGATOR SPONSORED RESEARCH CONCEPT FORM Covis Pharma is committed to advancing science by supporting external independent research activities.Specific areas of interest related to respiratory diseases (Asthma & COPD): Current treatment...

Medical Affairs

Medical InformationUnited StatesAdverse Events or Product Complaints To report suspected adverse events or product complaints in the United States, please call 1-877-411-2510 (option #1) or email [email protected] (option #2). You may also report suspected...

Educational Grant Application

Educational Grant ApplicationEDUCATIONAL GRANT REQUEST FORMACCREDITED AND NON-ACCREDITED EDUCATIONAL ACTIVITIES (FORMULAIRE DE DEMANDE DE SUBVENTION À DES FINS ÉDUCATIVES (ACTIVITÉS ACCRÉDITÉES ET NON ACCRÉDITÉES) )Grant requests should be submitted to Covis at least...

2013

News release 2013

2015

News release 2015

2017

News release 2017

2018

News release 2018

2021

News release 2021

Skip to content